Clinical trial
A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease
NCT01491386 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease
- Lead sponsor
- Medtronic Spinal and Biologics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 1998
- Completion date
- October 31, 2002
- Enrollment
- 279 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative disc disease